2 hours ago
1
J Studios
Amphastar Pharmaceuticals (NASDAQ:AMPH) has been upgraded to Buy from Hold at Needham after getting FDA approval for its generic iron sucrose injection to treat anemia associated with chronic kidney disease.
Needham analysts believe that this approval marks a significant milestone
English (US) ·